This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Mary Newman: Innovator in Dry Eye Disease Treatment
Introduction
Mary Newman is a prominent inventor based in Brisbane, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dry eye diseases. Her innovative work has led to the development of formulations that aim to improve the quality of life for individuals suffering from this condition.
Latest Patents
Mary Newman holds 1 patent for her invention titled "LFA-1 inhibitor formulations." This patent provides formulations, methods, and kits specifically designed for the treatment of dry eye diseases. The invention describes stabilized pharmaceutical compositions comprising a compound of Formula 1, which are intended for various uses, including the treatment of dry eye syndrome. Additionally, the patent outlines methods and ingredients that enhance the stability of these compositions.
Career Highlights
Mary Newman is associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.
Collaborations
Some of her notable coworkers include William A Hunke and James Zeller. Their collaboration has likely fostered an environment of innovation and creativity, leading to advancements in the treatment of dry eye diseases.
Conclusion
Mary Newman is a trailblazer in the pharmaceutical industry, with her innovative patent addressing a significant health issue. Her work continues to impact the lives of many individuals suffering from dry eye diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile